While large differences by race/ethnicity in breast cancer survival are well established, it is
unknown whether differences in quality of chemotherapy delivered explain the racial/ethnic …

Objective. To examine racial disparities associated with breast cancer treatment and survival
in elderly patients with early stage operable breast cancer. Methods. We studied 23,110 …

Purpose Black women with breast cancer are known to have poorer survival than white
women. Suboptimal treatment may compromise the survival benefits of adjuvant …

Recent breast cancer treatment studies conducted in large urban settings have reported
racial disparities in the appropriate use of adjuvant chemotherapy. This article presents the …

Purpose We conducted a systematic review and meta-analysis to measure the extent to
which race is associated with delayed initiation or receipt of inadequate chemotherapy …

Background After controlling for baseline disease factors, researchers have found that black
women have worse breast cancer survival, and this suggests that treatment differences may …

Background Black patients with breast cancer may be at greater risk for chemotherapy-
related hematologic toxicity than white patients because of lower baseline blood cell counts …

BACKGROUND African‐American women have a significantly worse prognosis from breast
carcinoma compared with white women, even when the stage at diagnosis is equivalent …

Purpose To explore racial differences in the use and outcome of neoadjuvant chemotherapy
for breast cancer. Methods The National Cancer Data Base was queried to identify women …

BACKGROUND: Incidence and mortality of breast cancer vary according to demographic
factors such as age, race/ethnicity, socioeconomic status (SES), and geographic region. This …